Zyneyro

ZYNEYRO is a spin-out from the University of Copenhagen and Marigold Innovation, developing next-generation treatments for chronic pain without the current typical side effects. Scientific Foundation Built on over 15 years of neuroscience research, our platform targets the PICK1 scaffold protein. This is a key to the nerve changes that cause chronic pain, offering a novel approach to pain modulation. The Need Chronic pain affects 7–10% of the global population. Existing therapies are often limited by sedation, cognitive impairment, tolerance, and abuse potential. Zyneyro’s approach avoids these limitations. Lead Program: ZYN01 ZYN01 aims to develop a synthetic peptide therapy delivering rapid, reversible relief in models of chronic pain, without affecting normal pain perception or cognition. Partner With Us We are actively seeking strategic partnerships to further develop our platform. Let’s transform chronic pain treatment together.